The program of development of cancer chemotherapy in Japan.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007564:Japan; D008004:Licensure; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents